Successful rapid desensitization to the antibody-drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma.
Fiche publication
Date publication
février 2016
Journal
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Auteurs
Membres identifiés du Cancéropôle Est :
Dr OJEDA-URIBE Mario
Tous les auteurs :
Fizesan M, Boin C, Aujoulat O, Newinger G, Ghergus D, Watier H, Lustig H, Ojeda-Uribe M
Lien Pubmed
Mots clés
Adult, Antineoplastic Combined Chemotherapy Protocols, administration & dosage, Bleomycin, administration & dosage, Cyclophosphamide, administration & dosage, Doxorubicin, administration & dosage, Etoposide, administration & dosage, Hodgkin Disease, drug therapy, Humans, Immunoconjugates, immunology, Ki-1 Antigen, immunology, Male, Prednisone, administration & dosage, Procarbazine, administration & dosage, Vincristine, administration & dosage
Référence
J Oncol Pharm Pract. 2016 Feb;22(1):188-92